中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Jaypirca
    Jaypirca
    departments：肿瘤科
    drug：片剂
    Active：pirtobrutinib
    indication：治疗至少接受过两种系统治疗（包括BTK抑制剂）的成年人复发或难治性地幔细胞淋巴瘤
    Licensor：Loxo Oncology, Inc.
    Approved Country/Region：FDA
    Approval time：2023-01-27